Measurable residual disease as an actionable biomarker in acute myeloid leukemia. Ready or not?
Year: 2025
Type: article
Source: Current Opinion in Oncology
Institution: University of Rome Tor Vergata
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4414710681
